Effects of a specific MCHR1 antagonist (GW803430) on energy budget and glucose metabolism in diet-induced obese mice

A guide to analysis of mouse energy metabolism

(2011) Matthias H Tschöp et al.   NATURE METHODS

Effects of Chronic Oral Rimonabant Administration on Energy Budgets of Diet-Induced Obese C57BL/6 Mice

(2011) Li-Na Zhang et al.   Obesity

Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone

(2010) R. M. Sears et al.   JOURNAL OF NEUROSCIENCE

Mechanism of the anti-obesity effects induced by a novel Melanin-concentrating hormone 1-receptor antagonist in mice

(2009) Masahiko Ito et al.   BRITISH JOURNAL OF PHARMACOLOGY

Preclinical Evaluation of Melanin-Concentrating Hormone Receptor 1 Antagonism for the Treatment of Obesity and Depression

(2009) D. R. Gehlert et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Dysregulation of the Mesolimbic Dopamine System and Reward in MCH−/− Mice

(2008) Pavlos Pissios et al.   BIOLOGICAL PSYCHIATRY

The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice

(2008) Douglas A. Marsteller et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice

(2007) Mikael Bjursell et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM